Kun Ke

A highly experienced Interventional Radiologist with over 10 years of clinical practice at Xiehe Hospital, Fujian Medical University. Specialized in interventional treatments for liver and vascular diseases, I am proficient in various catheter, guidewire, and puncture techniques. My expertise extends to advanced imaging-guided procedures and research in the field of interventional radiology. Committed to continuous learning and professional development, I actively participate in academic conferences and collaborate with multidisciplinary teams to deliver high-quality patient care.

Research Projects

• 2024 Natural Science Foundation of Fujian Province
  Project Title: Study on the Role and Mechanism of CD74 Regulating Macrophage Phagocytosis in Atherosclerosis (2024J01123679)
  Duration: May 2024 - April 2027
  Role: Principal Investigator
• 2020 Startup Fund of Fujian Medical University
  Project Title: Study on the Promotion of Cholangiocarcinoma Cell Invasion by Thyroxine Transport Protein in the Tumor Microenvironment (2020QH1074)
  Duration: April 2021 - April 2024
  Role: Principal Investigator
  Status: Completed

Publications

• Ke K, Wu Z, Lin J, Lin L, Huang N, Yang W. (2024). Increased Expression of CD74 in Atherosclerosis Associated with Inflammatory Responses of Endothelial Cells and Macrophages. Biochem Genet, 62(1), 294-310.
• Ke K, Lin J, Huang N, Yan L, Liao R, Yang W. (2023). Transthyretin Promotes the Invasion of Combined Hepatocellular Cholangiocarcinoma by Tumor-Associated Macrophages. Cancer Rep (Hoboken), 6(10), e1888.
• Lin LW, Ke K, Yan LY, Chen R, Huang JY. (2023). Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors Plus Programmed Death-1 Inhibitors for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization. Front Oncol, 13:1178428. (Co-first author)